Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to -$2.9 million.

  • Cresco Labs' Gains from Investment Securities fell 131722.69% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.5 million, marking a year-over-year decrease of 12377.58%. This contributed to the annual value of $9.2 million for FY2024, which is 8703.03% down from last year.
  • Cresco Labs' Gains from Investment Securities amounted to -$2.9 million in Q3 2025, which was down 131722.69% from -$9.1 million recorded in Q2 2025.
  • In the past 5 years, Cresco Labs' Gains from Investment Securities registered a high of $73.6 million during Q4 2023, and its lowest value of -$62.4 million during Q3 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was $833000.0 (2021), whereas its average is $3.4 million.
  • Over the last 5 years, Cresco Labs' Gains from Investment Securities had its largest YoY gain of 72749.1% in 2022, and its largest YoY loss of 144083.04% in 2022.
  • Cresco Labs' Gains from Investment Securities (Quarter) stood at $3.2 million in 2021, then tumbled by 1440.83% to -$42.6 million in 2022, then skyrocketed by 272.64% to $73.6 million in 2023, then tumbled by 110.67% to -$7.8 million in 2024, then surged by 63.09% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q3 2025, -$9.1 million for Q2 2025, and -$1.7 million during Q1 2025.